Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Daniel Addison"'
Autor:
Omar M. Makram, Tochukwu Okwuosa, Daniel Addison, Jorge Cortes, Susan Dent, Malcolm Bevel, Sarju Ganatra, Sadeer Al‐Kindi, Catherine C Hedrick, Neal L Weintraub, Xiaoling Wang, Avirup Guha
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background Both cancer and cardiovascular disease (CVD) are the leading causes of death worldwide. Although our previous study detected a relationship between CVD and cancer incidence, limited evidence is available regarding the relationship between
Externí odkaz:
https://doaj.org/article/80024f6239cd41fabdebb1ffd099382e
Autor:
Ashish Kumar, MD, Sumanth Khadke, MD, Sadeer AlKindi, MD, Sanjay Rajagopalan, MD, Khurram Nasir, MD, Dhruv Kazi, MD, Javaria Ahmad, MD, Safi Khan, MD, Aarti Asnani, MD, Daniel Addison, MD, Diego Sadler, MD, Anita Deswal, MD, Ana Barac, MD, Avirup Guha, MD, Jennifer Liu, MD, Daniel Lenihan, MD, Tomas G. Neilan, MD, Salim Hayek, MD, Joerg Hermann, MD, Anju Nohria, MD, Sourbha S. Dani, MD, Sarju Ganatra, MD
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101106- (2024)
Background: Evidence regarding the effect of long-term exposure to particulate matter (PM) 2.5 and comorbid cancer and cardiovascular disease (CVD) mortality is limited. Objectives: In this study, the author report the association between long-term e
Externí odkaz:
https://doaj.org/article/09a0ca57ee78457696a46d5d8d838472
Autor:
Ikeoluwapo Kendra Bolakale-Rufai, Alexander Shinnerl, Shannon M. Knapp, Amber E. Johnson, Selma Mohammed, LaPrincess Brewer, Asad Torabi, Daniel Addison, Sula Mazimba, Khadijah Breathett
Publikováno v:
American Heart Journal Plus, Vol 39, Iss , Pp 100370- (2024)
Background: Transcatheter aortic valve replacement (TAVR) are not offered equitably to vulnerable population groups. Adequate levels of insurance may narrow gaps among patients with higher social vulnerability index (SVI). Among a national population
Externí odkaz:
https://doaj.org/article/d65623d3c1134495b311685932cf936a
Autor:
Sherry-Ann Brown, Craig Beavers, Brenton Bauer, Richard K. Cheng, Generika Berman, Catherine H. Marshall, Avirup Guha, Prantesh Jain, Austin Steward, Jeanne M. DeCara, Iredia M. Olaye, Kathryn Hansen, Jim Logan, Carmen Bergom, Carri Glide-Hurst, Irving Loh, John Alan Gambril, James MacLeod, Ragasnehith Maddula, Peter J. McGranaghan, Akshee Batra, Courtney Campbell, Abdulaziz Hamid, Fatma Gunturkun, Robert Davis, John Jefferies, Michael Fradley, Katherine Albert, Anne Blaes, Indrajit Choudhuri, Arjun K. Ghosh, Thomas D. Ryan, Ogochukwu Ezeoke, Douglas J. Leedy, Wadsworth Williams, Sebastian Roman, Lorenz Lehmann, Abdullah Sarkar, Diego Sadler, Elizabeth Polter, Kathryn J. Ruddy, Neha Bansal, Eric Yang, Brijesh Patel, David Cho, Alison Bailey, Daniel Addison, Vijay Rao, Joshua E. Levenson, Dipti Itchhaporia, Karol Watson, Martha Gulati, Kim Williams, Donald Lloyd-Jones, Erin Michos, Julie Gralow, Hugo Martinez
Publikováno v:
American Heart Journal Plus, Vol 38, Iss , Pp 100354- (2024)
As cancer therapies increase in effectiveness and patients' life expectancies improve, balancing oncologic efficacy while reducing acute and long-term cardiovascular toxicities has become of paramount importance. To address this pressing need, the Ca
Externí odkaz:
https://doaj.org/article/8043007b5ee04ac89d1b9f4d2fd3cdc7
Autor:
Avirup Guha, Anubhav Jain, Ankita Aggarwal, Amit K. Dey, Sourbha Dani, Sarju Ganatra, Francis E. Marchlinski, Daniel Addison, Michael G. Fradley
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The aim of this study is to assess the burden of AF-related hospitalizations inclusive of inflation-adjusted cost-of-care and length-of-stay (LOS) among cancer patients and the impact of direct current cardioversion (DCCV) on thes
Externí odkaz:
https://doaj.org/article/e753efc0c630434a85c1c7949515530d
Autor:
Lisa Kim, Brian Fowler, Courtney M. Campbell, Jeremy Slivnick, Haseeb Nawaz, Yaquta Kaka, Patrick Ruz, Ajay Vallakati, Ragavendra Baliga, Sumithira Vasu, Daniel Addison
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background Gilteritinib is a novel FMS-like tyrosine kinase 3 inhibitor recently approved by the United States Food and Drug Administration in 2018 for relapsed or refractory acute myeloid leukemia. However, gilteritinib may be associated wi
Externí odkaz:
https://doaj.org/article/b4306920ee594eb89324f714cb2457be
Autor:
Sherry-Ann Brown, Generika Berman, Jim Logan, Diego Sadler, Rohit Moudgil, Brijesh Patel, Marielle Scherrer-Crosbie, Daniel Addison, Richard K. Cheng, Arco J. Teske
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/2e81b1e70f7a434b927f1835df3cb992
Autor:
James MacLeod, Mohamed Abdelrahim, Sabrina Painter, Ragasnehith Maddula, Austin Steward, Abdulaziz Hamid, Richard K. Cheng, Vlad Zaha, Daniel Addison, Brenton Bauer, Sherry-Ann Brown
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/48f4efb62039433fbfb611b6b7324fce
Autor:
Avirup Guha, Cesar Caraballo, Prantesh Jain, P. Elliott Miller, Jocelyn Owusu‐Guha, Katherine A.A. Clark, Eric J. Velazquez, Tariq Ahmad, Lauren A. Baldassarre, Daniel Addison, Neal L. Weintraub, Nihar R. Desai
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2866-2875 (2021)
Abstract Aims Improved cancer survivorship has led to a higher number of anthracycline‐induced cardiomyopathy patients with end‐stage heart failure. We hypothesize that outcomes following continuous‐flow LVAD (CF‐LVAD) implantation in those w
Externí odkaz:
https://doaj.org/article/7104df3c2cc7464abcfc50a3f46d9f5e
Autor:
Ragasnehith Maddula, James MacLeod, Sabrina Painter, Tyson McLeish, Austin Steward, Andrea Rossman, Abdulaziz Hamid, Mahi Ashwath, Hugo R. Martinez, Avirup Guha, Brijesh Patel, Daniel Addison, Anne Blaes, Indrajit Choudhuri, Sherry-Ann Brown
Publikováno v:
American Heart Journal Plus, Vol 20, Iss , Pp 100192- (2022)
Study objective: Cancer and heart disease are leading causes of mortality, and cardio-oncology is emerging as a new field addressing the cardiovascular toxicities related to cancer and cancer therapy. Interdisciplinary research platforms that incorpo
Externí odkaz:
https://doaj.org/article/ff07ea8a76674c82b0989b2559ed350b